Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma
Purpose: To assess the safety and efficacy of a ciliary neurotrophic factor (CNTF) intraocular implant on neuroprotection and neuroenhancement in glaucoma. Design: Open-label, prospective, phase I clinical trial. Participants: A total of 11 participants were diagnosed with primary open-angle glaucom...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2023-09-01
|
| Col·lecció: | Ophthalmology Science |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2666914523000301 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|